eNauka - pregled
Pregled prema Autor Ozelo, MC
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2013 | Association between predicted FVIII levels and risk of bleeding episodes in clinical trials with turoctocog alfa, a new rFVIII product from Novo Nordisk | Ozelo, MC; Veljkovic, Dobrila K; Klamroth, R; Misgav, M; Nielsen, R; Groth, A | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2015 | PO251-WED Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A | Lentz, SR; Kempton, CL; Janic, Dragana M   ; Savic, Aleksandar D ; Cerqueira, MH; Ozelo, MC; Recht, M; Oldenburg, J; Tiede, Andreas; Suzuki, Takashi;
Matytsina, Irina; Zeuthen, N; Santagostino, E;
| Conference Paper | Mp. category will be shown later |
| 2012 | Safety and efficacy of turoctocog alfa during prevention and treatment of bleeds in adult and adolescent patients with severe haemophilia A | Lentz, SR; Misgav, M; Ozelo, MC; Zupancic-Salek, Silva; Veljkovic, Dobrila K; Recht, M; Cerqueira, MH; Tiede, Andreas; Brand, B; Mancuso, ME;
Martinowitz, U;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |